Search Results
'Preclinical Models to Investigate NK Cell-Targeted Immunotherapies' with Biocytogen
Immunodeficient Mouse Models to Support Prolonged Engraftment of Human NK and Tumor Cells
Advancing T cell Therapies Using B-hCD3 Mouse Models
Webinar: Next-Generation B-NDG Mice: Improved Immunodeficient Models for Research and Discovery
Biocytogen Company Overview 20221031
FcRn Therapies 2021 Conference Humanized Cytokine Models
Design and Screening of Bispecific ADCs Discovered in RenLite Common Light Chain Antibody Mice
Humanized Immune Checkpoint Mice Improve Translatability of Novel Immunotherapies
JK06, a biparatopic ADC in preclinical development
Biocytogen Pharmaceuticals（Beijing）Co., Ltd. (ENG)
BioMice_Biocytogen
Gene editing of NKG2A to enhance NK cell cytotoxicity against multiple myeloma cells
